Boletín Oficial del Registro Mercantil · 07 Sep 2026 · 2 vistas
Takeda Pharmaceuticals renews its board with the entry of Pablo Sierra
Por FactBox Admin

Takeda Farmacéutica España Sociedad Anónima has registered the renewal of its board of directors in the Commercial Registry of Madrid. The act, registered under reference BORME-A-2026-172-28, records the cessation of Sergio Pulla Méndez as director and the appointment of Pablo Sierra Gracia to fill his position.
The registration appears in the First Section of the Official Gazette of the Commercial Registry (BORME) number 172, corresponding to Monday, September 7, 2026, within the registered acts of the province of Madrid, on page 42666.
A change in the governing body
The move was formalized with a registration date of August 31, 2026, as stated in the registration data of the entry. The company, one of the main subsidiaries in Spain of the Japanese pharmaceutical group Takeda, thus updates the composition of its highest administrative body.
The registration data of the entry are as follows:
- Registration sheet: H M 89351
- Registration: I/A 146
- Registration date: 31.08.26
- Section 8 of the Commercial Registry of Madrid
Cessations and appointments
The registered act combines two complementary operations regarding the company’s board of directors:
- Cessation/resignation: Sergio Pulla Méndez leaves his position as director.
- Appointment: Pablo Sierra Gracia joins as the new director.
The announcement does not detail the reasons for the cessation nor the professional profile of the new director, limiting itself to the registration record of both movements, as required by commercial regulations for the publicity of corporate acts.
Relevance for the sector
The renewal of the board of Takeda Farmacéutica España occurs at a time of special attention on the pharmaceutical industry in Spain, both due to its weight in the healthcare system and the interest it generates among sector investors. Changes in the administrative body of a subsidiary of a multinational group of this size are usually read as an indication of the company’s strategic orientation in the Spanish market.
The registration is published in BORME number 172, of September 7, 2026, First Section, page 42666, with the official reference BORME-A-2026-172-28, and is verifiable on the electronic headquarters of the Official State Gazette.
Source: Official Gazette of the Commercial Registry (BORME), no. 172, September 7, 2026, First Section, p. 42666 (official reference: BORME-A-2026-172-28).
Fuente: Boletín Oficial del Registro Mercantil · Boletín Oficial del Registro Mercantil de 2026-09-07